Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Total Current Assets
Iterum Therapeutics PLC
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Total Current Assets
$25.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Total Current Assets
$2.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Total Current Assets
$3.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
21%
|
CAGR 10-Years
21%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Total Current Assets
$136m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Total Current Assets
$164.1m
|
CAGR 3-Years
203%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Total Current Assets
€306.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
See Also
What is Iterum Therapeutics PLC's Total Current Assets?
Total Current Assets
25.6m
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Total Current Assets amounts to 25.6m USD.
What is Iterum Therapeutics PLC's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-23%
Over the last year, the Total Current Assets growth was -59%. The average annual Total Current Assets growth rates for Iterum Therapeutics PLC have been 6% over the past three years , -23% over the past five years .